KEMRI-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.
Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Influenza Other Respir Viruses. 2023 Sep;17(9):e13185. doi: 10.1111/irv.13185.
We estimated the secondary attack rate of SARS-CoV-2 among household contacts of PCR-confirmed cases of COVID-19 in rural Kenya and analysed risk factors for transmission.
We enrolled incident PCR-confirmed cases and their household members. At baseline, a questionnaire, a blood sample, and naso-oropharyngeal swabs were collected. Household members were followed 4, 7, 10, 14, 21 and 28 days after the date of the first PCR-positive in the household; naso-oropharyngeal swabs were collected at each visit and used to define secondary cases. Blood samples were collected every 1-2 weeks. Symptoms were collected in a daily symptom diary. We used binomial regression to estimate secondary attack rates and survival analysis to analyse risk factors for transmission.
A total of 119 households with at least one positive household member were enrolled between October 2020 and September 2022, comprising 503 household members; 226 remained in follow-up at day 14 (45%). A total of 43 secondary cases arose within 14 days of identification of the primary case, and 81 household members remained negative. The 7-day secondary attack rate was 4% (95% CI 1%-10%), the 14-day secondary attack rate was 28% (95% CI 17%-40%). Of 38 secondary cases with data, eight reported symptoms (21%, 95% CI 8%-34%). Antibody to SARS-CoV-2 spike protein at enrolment was not associated with risk of becoming a secondary case.
Households in our setting experienced a lower 7-day attack rate than a recent meta-analysis indicated as the global average (23%-43% depending on variant), and infection is mostly asymptomatic in our setting.
我们估计了肯尼亚农村地区经 PCR 确诊的 COVID-19 病例的家庭接触者中 SARS-CoV-2 的二次感染率,并分析了传播的风险因素。
我们招募了新发病例 PCR 确诊病例及其家庭成员。在基线时,收集了一份问卷、一份血液样本和鼻咽拭子。在家庭中第一个 PCR 阳性后 4、7、10、14、21 和 28 天,对家庭成员进行随访;每次随访时采集鼻咽拭子,用于定义二次感染病例。每两周采集一次血液样本。每天通过症状日记收集症状。我们使用二项式回归估计二次感染率,使用生存分析分析传播的风险因素。
在 2020 年 10 月至 2022 年 9 月期间,共招募了 119 个至少有一个阳性家庭成员的家庭,共包括 503 名家庭成员;在第 14 天(45%)时,仍有 226 人在随访中。在首例病例确诊后的 14 天内,共出现了 43 例二次感染病例,仍有 81 名家庭成员检测结果为阴性。7 天二次感染率为 4%(95%CI 1%-10%),14 天二次感染率为 28%(95%CI 17%-40%)。在 38 例有数据的二次感染病例中,有 8 例报告了症状(21%,95%CI 8%-34%)。在招募时,针对 SARS-CoV-2 刺突蛋白的抗体与成为二次感染病例的风险无关。
在我们的研究环境中,家庭的 7 天感染率低于最近的一项荟萃分析(23%-43%,取决于变体)所表明的全球平均水平,而且在我们的研究环境中,感染大多无症状。